Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
January-2016 Volume 35 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2016 Volume 35 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells

  • Authors:
    • Ichiro Ota
    • Takashi Masui
    • Miyako Kurihara
    • Jong-In Yook
    • Shinji Mikami
    • Takahiro Kimura
    • Keiji Shimada
    • Noboru Konishi
    • Katsunari Yane
    • Toshiaki Yamanaka
    • Tadashi Kitahara
  • View Affiliations / Copyright

    Affiliations: Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Nara 634-8522, Japan, Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8522, Japan, Department of Oral Pathology, Oral Cancer Research Institute, College of Dentistry, Yonsei University, Seoul 120-752, Republic of Korea, Department of Pathology, Nara Medical University, Kashihara, Nara 634-8522, Japan, Department of Otolaryngology, Kinki University School of Medicine, Nara Hospital, Ikoma, Nara 630-0293, Japan
  • Pages: 261-266
    |
    Published online on: October 26, 2015
       https://doi.org/10.3892/or.2015.4348
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Epithelial-mesenchymal transition (EMT) is a key process involved in the invasion and metastasis of cancer cells. Furthermore, EMT can induce a cancer stem cell (CSC)‑like phenotype in a number of tumor types. We demonstrated that Snail is one of the master regulators that promotes EMT and mediates cancer cell migration and invasion in many types of malignancies including head and neck squamous cell carcinoma (HNSCC). In the present study, we investigated the role of Snail in inducing and maintaining CSC-like properties through EMT in HNSCC. We established HNSCC cell lines transfected with Snail. Stem cell markers were evaluated with real-time RT-PCR and western blot analysis. CSC properties were assessed using sphere formation and WST-8 assays as well as chemosensitivity and chick chorioallantoic membrane in vivo invasion assays. Introduction of Snail induced EMT properties in HNSCC cells. Moreover, Snail-induced EMT maintained the CSC-like phenotype, and enhanced sphere formation capability, chemoresistance and invasive ability. These data suggest that Snail could be one of the critical molecular targets for the development of therapeutic strategies for HNSCC.

Introduction

Epithelial-mesenchymal transition (EMT) is an important process in tumor progression that causes epithelial cells to acquire a migratory mesenchymal phenotype (1,2). EMT is thought to be a critical step in the induction of cell invasion and tumor metastasis (1). Furthermore, it has been shown that cells with an EMT phenotype are more resistant to chemoradiotherapy in regards to head and neck squamous cell carcinoma (HNSCC) (3–6).

It has been indicated in recent studies that EMT induces cancer stem cell (CSC)-like properties in many different types of malignant tumors and that both EMT and a CSC-like phenotype are associated with treatment resistance (7–9). Prince et al demonstrated that the purified CD44+ population of HNSCC cells possesses the self-renewing properties of CSCs (10). Aldehyde dehydrogenase 1 (ALDH1) has also been shown to be a putative marker of CSCs in HNSCC (11). Furthermore, Chen et al showed that CD44+/ALDH1+ cells resist radiotherapy and may serve as a reservoir for developing tumors and metastasis (6). Additionally, the CD44high/EGFRlow subpopulation exhibited the EMT phenotype and resistance to treatment in HNSCC (12). Moreover, a high level of expression of variant isoforms of CD44 (CD44v) could suppress the clustering of EGFR at the surface of HNSCC cells and thereby negatively regulate EGFR signaling in the absence of a differentiation stimulus, suggesting that CD44v-negative HNSCC cells rely on EGFR activity for survival (13).

However, the source and the mechanism of development in regards to CSCs have not yet been fully elucidated. Moreover, it has been shown that it is difficult to extract pure CSC populations with only CSC markers such as CD44 and ALDH1. The same result is shown with side populations (14). Therefore, it is necessary not only to identify novel CSC markers but also to clarify the mechanism of CSC development.

Snail, a member of the zinc-finger transcription factor family, plays an important role in EMT by directly repressing epithelial markers such as E-cadherin and by upregulating mesenchymal markers (7,15–19). Several studies have shown that Snail-related transcription factors play a transcriptional and regulatory role in the invasion, metastasis and poor outcome in different type of malignancies, including HNSCC (20,21). These findings suggest that Snail expression may regulate CSC-like properties via EMT in HNSCC.

We previously demonstrated that Snail overexpression induced EMT, including cancer cell migration and invasion, and promotes CSC-like phenotype such as CD44+/ALDH1+ in head and neck cancer cells (22). However, the key role of Snail on the stemness of CSC in HNSCC has not been fully elucidated. In the present study, we first demonstrated that Snail-induced EMT gains CSC-like phenotype such as upregulation of stem cell markers, including CD44 and ALDH1, and enhanced CSC-like properties such as sphere formation capability, chemoresistance and in vivo cancer invasion and metastasis in HNSCC.

Materials and methods

Cell lines and culture

Human HNSCC cells, SAS and HSC-4, were employed in the present study. SAS and HSC-4 cells, obtained from the Japanese Cancer Research Resource Bank (Tokyo, Japan), were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (both from Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco, Grand Island, NY, USA) at 37°C in 5% CO2.

Transient transfection

The cDNA fragment encoding human Snail (NM_005985.2) was inserted into the pCR 3.1 mammalian expression vector (Invitrogen). For transient transfection, SAS and HSC-4 cells (1.5×105 cells) were plated into 6-well culture plates and allowed to adhere for 12 h. Then, the cells were transfected with 2 µg of either pCR 3.1-Snail or pCR 3.1-vector (without insert DNA) with Lipofectamine 2000 reagent (invitrogen) according to the manufacturer's instructions. We established SAS-Snail and HSC-4-Snail as Snail-expressing cell lines and their respective control cell lines.

Immunoblot analysis and antibodies

Total protein extracts were prepared according to the freeze-thawing lysis method, and protein concentrations were measured with a bovine serum albumin (BSA) protein assay. Samples of extract containing 20 µg of protein were then separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes. After washing with phosphate-buffered saline with Tween-20 (PBST), the membranes were incubated first with rabbit anti-Nanog, rabbit anti-Oct4, rabbit anti-ABCG2, rabbit anti-EGFR and rabbit anti-pEGFR (Cell Signaling Technology, Danvers, MA, USA; diluted 1:1,000), rabbit anti-Sox2 and rabbit anti-Bmi1 (Abcam, Cambridge, MA, USA; diluted 1:1,000) antibodies at 4°C overnight and then with peroxidase-conjugated secondary anti-rabbit antibody or goat immunoglobulin G (IgG) (diluted 1:1,000; Cell Signaling Technology) for 1 h. After rinsing in PBST, immunodetection was accomplished using an ECL western blot analysis detection reagent and analysis system. The membranes were subsequently exposed to X-ray film as previously described (23).

Real-time RT-PCR

Total RNA was isolated from each cell line using the RNeasy Mini kit (Qiagen, Hilden, Germany). cDNA was then reverse transcribed using ReverTra Ace® qPCR rT master mix with gDNA remover (Toyobo Life Science, Tokyo, Japan) according to the manufacturer's instructions. Real-time RT-PCR was then carried out using the primers shown in Table I and EXPRESS SYBR®-GreenER™ qPCR SuperMix with premixed ROX (Invitrogen). PCR was performed with an initial step of 3 min at 95°C followed by 40 cycles of 3 sec at 95°C and 20 sec at 60°C. The level of target mRNA was normalized to the mRNA level of GAPDH as an internal standard.

Table I

Primers for real-time RT-PCR.

Table I

Primers for real-time RT-PCR.

GenePrimer sequence
ABCG2S 5′-CATGTACTGGCGAAGAATATTTGGT-3′
(NM_004827)A 5′-CACGTGATTCTTCCACAAGCC-3′
Bmi1S 5′-AAATGCTGGAGAACTGGAAAG-3′
(NM_005180)A 5′-CTGTGGATGAGGAGACTGC-3′
NanogS 5′-ATTCAGGACAGCCCTGATTCTTC-3′
(NM_024865)A 5′-TTTTTGCGACACTCTTCTCTGC-3′
Oct4S 5′-GTGGAGAGCAACTCCGATG-3′
(NM_002701)A 5′-TGCTCCAGCTTCTCCTTCTC-3′
Sox2S 5′-CGAGTGGAAACTTTTGTCGGA-3′
(NM_003106)A 5′-TGTGCAGCGCTCGCAG-3′
GAPDHS 5′-CATCATCCCTGCCTCTACTG-3′
(NM_002046)A 5′-GCCTGCTTCACCACCTTC-3′

[i] S, sense; A, antisense.

Sphere formation assay

The capability of self-renewal was assessed using 96-well NanoCulture plates (Scivax, Tokyo, Japan). Cells (1×104) were seeded and cultured for 1 week in DMEM supplemented with 10% FBS or serum-free medium, and phase-contrast images were obtained.

Chemotherapy of the cultured cells

Chemosensitivity was assessed using the Cell Counting Kit-8 (WST-8 cleavage; Dojindo, Mashikimachi, Japan) as previously described (23). The cells were seeded into 96-well plates at an initial density of 4×103 cells/well and incubated for 24 h. For chemotherapy, cisplatin (Nihon Kayaku Co., Tokyo, Japan) at a concentration of 1.0 µM was added to each well. Following incubation for an additional 48 h, 10 µl of WST-8 solution was added to each well, and the plate was incubated for a further 2 h. The absorbance of each well at 450 nm (reference wavelength at 620 nm) was measured by a Multiscan FC microplate photometer (Thermo Scientific). The measurement was repeated at least three times for each cell line.

Chick chorioallantoic membrane (CAM) in vivo invasion assay

The CAM in vivo invasion assay was conducted using 11-day-old chick embryos wherein HSC-4 or the transfected cells (105 cells labeled with green Fluoresbrite carboxylated polystyrene nanospheres of 45-nm diameter; Polysciences) were seeded atop the CAM and incubated for three days as previously described (24,25). The CAM was dropped without damaging the epithelial basement membrane (BM) by applying gentle negative pressure at the air sac, and an opening of ~1 cm2 was cut in the shell above the CAM with an electric drill.

Statistical analysis

Data are presented as the mean ± standard error (SE). Experimental differences between groups were assessed with a t-test. The differences were considered to indicate a statistically significant result at P<0.05.

Results

Snail expression induces a CSC-like phenotype

To elucidate that EMT by Snail expression induces a stem cell-like phenotype in HNSCC cells, we investigated the expression of CSC surface markers in HNSCC cells. We previously demonstrated that expression of both CD44 and ALDH1 increased in SAS-Snail and HSC-4-Snail cells compared with their control cells (22). RT-PCR analysis revealed that mRNA levels of several stem cell markers, Bmi1, Nanog, Oct4, Sox2 and ABCG2, which are drug-resistant proteins, were high in the Snail-transfected cells compared with the levels in the controls (Fig. 1A). Moreover, at the protein level, Nanog, Bmi1 and ABCG2 were also upregulated in the Snail-transfected cells, whereas the expression of Oct4 and Sox2 showed no difference between the Snail-expressing cells and the controls (Fig. 1B). These data revealed that Snail-induced EMT elicits a CSC-like phenotypic change as CD44+/ALDH+, and directly regulates the expression of Nanog, Bmi1 and ABCG2. In addition, there were no differences in the level of EGFR protein between the Snail-transfected cells and the controls, whereas, the levels of phospho-EGFR protein increased in the Snail-transfected cells compared with that in the control (Fig. 1B).

Figure 1

Snail induces expression of several stem cell markers in SAS and HSC-4 cells. (A) relative expression of mRNA-encoding stem cell genes ABCG2, Bmi1, Nanog, Oct4 and Sox2 normalized to the endogenous control GAPDH. (B) The level of each protein was determined by western blot analysis with β-actin used as the internal control. Data represent the mean ± SE. *P<0.05.

Snail induces CSC properties

The transfection of Snail induced tumor sphere-forming capability in the SAS and HSC-4 cells, but not in the control cells (Fig. 2). Furthermore, the cells transfected with Snail showed significantly low chemosensitivity at 1.0 µM of cisplatin, as compared with the control cells (Fig. 3). Thus, these data revealed that the acquisition of a CSC-like phenotype caused by Snail-induced EMT results in enhancement of the ability of sphere formation and chemoresistance in the HNSCC cells.

Figure 2

Transfection of Snail increases tumor sphere-forming capability. Tumor sphere-forming capability was assessed by a sphere formation assay. Cells were seeded and cultured for 1 week.

Figure 3

Snail expression enhances the chemoresistance to cisplatin in SAS and HSC-4 cells. Cell viability was assessed using WST-8 assay for chemosensitivity. Cells were incubated for 24 h. For chemotherapy, the cells were treated with 1.0 µm of cisplatin. Following an additional 48 h, cell viability was determined by WST-8 assay. Data are shown as the mean ± Se. *P<0.05.

Snail induces EMT as a CSC property in vivo

We previously demonstrated that Snail-regulated EMT promotes CSC properties, including cell migration and invasion as well as E-cadherin suppression in HNSCC cells in vitro (22). Snail was also functional in inducing in vivo cancer invasive progression of non-invasive SAS and HSC-4 cells, as noted in the crossing of cells into the BM in the CAM assay (Fig. 4).

Figure 4

Snail expression increases in vivo cell invasion in head and neck cancer cells. The non-invasive SAS and HSC-4 cells were transiently co-transfected with either a control (A) or Snail (B) labeled with green fluorescent nanospheres, respectively. The cells were cultured atop the embryonic chick chorioallantoic membrane (CAM) for 3 days and the fixed tissue sections then were examined by fluorescence microscopy. The upper face of the CAM is indicated by dashed white lines; invasive cancer cells (green) are denoted by yellow arrows. Scale bars, 200 µm.

Discussion

The identification of cell surface-specific markers of CSCs is critical for the possible establishment of target-specific cancer therapies. CD44 (10) and ALDH1 (11) have been reported to represent candidate markers of CSCs in HNSCC. Recently, CD271 (26) and CD10 (27) have been identified as additional markers of CSCs in HNSCC. However, it is difficult to extract CSCs selectively with such markers only. Several studies have indicated that there could be key markers of CSCs that regulate stemness genes, such as Bmi1, Nanog, Oct4, Sox2 and ABCG2 as follows.

Bmi1 has been demonstrated to play a role in the tumorigenesis of HNSCC (28,29). Expression of Bmi1, ALDH1 and Snail could be associated with the maintenance of stemness in CSCs and correlate with poor overall survival in HNSCC patients (30). Additionally, Bmi1 can regulate Snail and ALDH1 in inducing EMT and CSC properties (30). In present study, we obtained results consistent with those in our previous study (22).

Nanog maintains the pluripotency of embryonic stem cells and functionally blocks differentiation (31,32). Recent studies have demonstrated that Nanog promotes CSC properties, and the downregulation of Nanog inhibits sphere formation and tumor development (33–36). Another study suggested that Nanog was upregulated by TGF-β through Smad signaling and that Snail directly regulates Nanog promoter activity (37). Nanog expression was also upregulated in the present study, whereas there were no significantly differences in the expression of Oct4 and Sox2 between Snail-transfected cells and the controls. A previous study showed that Oct4 and Sox2 regulate Nanog expression (38). Therefore, direct regulation against the Nanog promoter by Snail may result in the suppression of Oct4 and Sox2.

Yoshikawa et al showed that the expression of EGFR was low in CSCs, but high in non-CSCs. They suggested that a high level of expression of variant isoforms of CD44 (CD44v) could suppress the clustering of EGFR at the surface of HNSCC cells and thereby negatively regulate EGFR signaling in the absence of a differentiation stimulus, and that CD44v-negative HNSCC cells rely on EGFR activity for survival (13). It has been suggested that the suppression of differentiation and treatment resistance in CSCs could be attributed to CD44v-positive and EGFR-negative expression. In the present study, Snail overexpression induced CSC-like properties, while there was no significantly difference in the expression of EGFR between the Snail-transfected cells and the controls. Furthermore, the expression of phospho-EGFR was enhanced in the Snail-transfected cells compared with the controls. However, this result is considered to be compatible with the findings in the previous study. It was predicted from the present study that the CSC-like properties acquired by Snail occurred not in all cells, but in a portion of them. This raises the possibility that upregulation of phospho-EGFR occurred in non-CSCs around CSCs. Wang et al showed that reduction in E-cadherin resulted in upregulation of EGFR transcriptionally and activation of EGFR resulted in overexpression of Snail (39). It was suggested that Snail could not only induce CSC-like properties, but also phosphorylates EGFR in non-CSCs, and it contributed to the maintenance of the microenvironment by interaction between CSCs and non-CSCs. Although the precise involvement of CD44 and EGFR expression by Snail in the regulation of CSCs remains to be elucidated, they may be involved in a latent effect. The critical mechanisms remain to be further investigated. The majority of studies on CSCs have been performed in vitro to evaluate clinical cancer therapies. Therefore, it should be noted that the results of in vitro studies on CSCs cannot be translated to the same cells in vivo. Although it is still too early to discuss its clinical efficiency, these data could support the hypothesis that the interaction between CSCs and non-CSCs contributes to cell proliferation and treatment resistance.

In addition, the upregulation of ABCG2 expression was also observed in the Snail-transfected cells. However, higher expression of ABCG2 was observed not in ALDH1+ cells, but in ALDH cells around CSCs (40). This suggests that ABCG2 itself is not a CSC marker, but the interaction between CSCs and the cells around CSCs results in upregulation of ABCG2. The upregulation of ABCG2 in the present study could similarly support the possibility that Snail contributes to the interaction between CSCs and non-CSCs.

Furthermore, we first showed that Snail regulates cancer cell invasion through EMT as a CSC-like property in HNSCC cells in vivo as well as in vitro (22). These data suggest that Snail can promote cancer invasion and metastasis as well as maintain the stemness similar to CSCs.

In summary, we demonstrated the possibility that Snail induces CSC-like properties through EMT and maintains stemness by upregulating various CSC markers. However, other transcription factors of EMT as well as Snail could be involved in the maintenance of CSCs and the microenvironment. These interactions between various CSC- and EMT-relating genes make it difficult to select a pure CSC population. Snail-induced EMT is also considered to play an essential role in tumor progression, such as cancer invasion and metastasis in vivo. Although the critical mechanisms remain to be further investigated, Snail could prove to be one of the valid targets in the treatment for HNSCC.

Acknowledgments

The present study was supported in part by Grants-in Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

References

1 

Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 233:706–720. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY, et al: Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res. 16:4561–4571. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J and García De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI

5 

Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT and Wong TT: Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One. 3:e20902008. View Article : Google Scholar : PubMed/NCBI

6 

Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, Chiou GY, Chang SC, Kao SY, Chiou SH, et al: Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 46:158–165. 2010. View Article : Google Scholar

7 

Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313. 2009. View Article : Google Scholar : PubMed/NCBI

12 

La Fleur L, Johansson AC and Roberg K: A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment. PLoS One. 7:e440712012. View Article : Google Scholar

13 

Yoshikawa M, Tsuchihashi K, Ishimoto T, Yae T, Motohara T, Sugihara E, Onishi N, Masuko T, Yoshizawa K, Kawashiri S, et al: xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res. 73:1855–1866. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Burkert J, Otto WR and Wright NA: Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and Chodosh LA: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 8:197–209. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, Chodosh LA, Cardiff RD and Gunther EJ: Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss. J Clin Invest. 118:51–63. 2008. View Article : Google Scholar

18 

Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, et al: A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol. 11:943–950. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in svitro. Oral Oncol. 37:65–71. 2001. View Article : Google Scholar

21 

Peinado H, Ballestar E, Esteller M and Cano A: Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 24:306–319. 2004. View Article : Google Scholar :

22 

Masui T, Ota I, Yook JI, Mikami S, Yane K, Yamanaka T and Hosoi H: Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells. Int J Oncol. 44:693–699. 2014.

23 

Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S, et al: REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol. 15:1224–1231. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, Cha SY, Ryu JK, Choi YJ, Kim J, et al: A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol. 8:1398–1406. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Ota I, Li XY, Hu Y and Weiss SJ: Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc Natl Acad Sci USA. 106:20318–20323. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Imai T, Tamai K, Oizumi S, Oyama K, Yamaguchi K, Sato I, Satoh K, Matsuura K, Saijo S, Sugamura K, et al: CD271 defines a stem cell-like population in hypopharyngeal cancer. PLoS One. 8:e620022013. View Article : Google Scholar : PubMed/NCBI

27 

Fukusumi T, Ishii H, Konno M, Yasui T, Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H, et al: CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma. Br J Cancer. 111:506–514. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Brunner M, Thurnher D, Pammer J, Geleff S, Heiduschka G, Reinisch CM, Petzelbauer P and Erovic BM: Expression of VEGF-A/C, VEGF-r2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol. 21:876–884. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Zhang P, Zhang Y, Mao L, Zhang Z and Chen W: Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS, Tseng LM, Hung SC, Kao SY, Chang CJ and Chiou SH: Bmi-1 regulates Snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol. 2011:pii: 609259. 2011. View Article : Google Scholar

31 

Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S and Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Abelev GI and Lazarevich NL: Control of differentiation in progression of epithelial tumors. Adv Cancer Res. 95:61–113. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Jeter Cr, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ and Tang DG: Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells. 27:993–1005. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ and Tang DG: NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 30:3833–3845. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM and Albers AE: Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI

37 

Dang H, Ding W, Emerson D and Rountree CB: Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics. BMC Cancer. 11:3962011. View Article : Google Scholar : PubMed/NCBI

38 

Niwa H: Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct. 26:137–148. 2001. View Article : Google Scholar : PubMed/NCBI

39 

Wang D, Su L, Huang D, Zhang H, Shin DM and Chen ZG: Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. Mol Cancer. 10:1162011. View Article : Google Scholar : PubMed/NCBI

40 

Emmink BL, Van Houdt WJ, Vries RG, Hoogwater FJ, Govaert KM, Verheem A, Nijkamp MW, Steller EJ, Jimenez CR, Clevers H, et al: Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology. 141:269–278. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ota I, Masui T, Kurihara M, Yook J, Mikami S, Kimura T, Shimada K, Konishi N, Yane K, Yamanaka T, Yamanaka T, et al: Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. Oncol Rep 35: 261-266, 2016.
APA
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T. ... Kitahara, T. (2016). Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. Oncology Reports, 35, 261-266. https://doi.org/10.3892/or.2015.4348
MLA
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T., Shimada, K., Konishi, N., Yane, K., Yamanaka, T., Kitahara, T."Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells". Oncology Reports 35.1 (2016): 261-266.
Chicago
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T., Shimada, K., Konishi, N., Yane, K., Yamanaka, T., Kitahara, T."Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells". Oncology Reports 35, no. 1 (2016): 261-266. https://doi.org/10.3892/or.2015.4348
Copy and paste a formatted citation
x
Spandidos Publications style
Ota I, Masui T, Kurihara M, Yook J, Mikami S, Kimura T, Shimada K, Konishi N, Yane K, Yamanaka T, Yamanaka T, et al: Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. Oncol Rep 35: 261-266, 2016.
APA
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T. ... Kitahara, T. (2016). Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. Oncology Reports, 35, 261-266. https://doi.org/10.3892/or.2015.4348
MLA
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T., Shimada, K., Konishi, N., Yane, K., Yamanaka, T., Kitahara, T."Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells". Oncology Reports 35.1 (2016): 261-266.
Chicago
Ota, I., Masui, T., Kurihara, M., Yook, J., Mikami, S., Kimura, T., Shimada, K., Konishi, N., Yane, K., Yamanaka, T., Kitahara, T."Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells". Oncology Reports 35, no. 1 (2016): 261-266. https://doi.org/10.3892/or.2015.4348
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team